MFS
DNA icon

Mirabella Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Mirabella Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,344
Closed -$44.7K – 250
2024
Q2 		$44.7K Buy
3,344
+2,707
+425% +$80.8K ﹤0.01% 417
2024
Q1 		$29.6K Buy
+637
New +$33K ﹤0.01% 485
2023
Q4 		– Sell
-1,300
Closed -$94.1K – 473
2023
Q3 		$94.1K Buy
+1,300
New +$104K 0.01% 347
2022
Q1 		– Sell
-408
Closed -$135K – 575
2021
Q4 		$135K Buy
+408
New +$194K 0.01% 346

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirabella Financial Services's DNA Position: Q3 2024 in Review

Mirabella Financial Services sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 3,344 shares — an estimated $44.7K sold.

Mirabella Financial Services first reported a position in DNA in Q4 2021 and held it in 4 quarters. The position peaked at $135K in Q4 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Mirabella Financial Services reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 3,344 Ginkgo Bioworks shares in Q3 2024, an estimated $44.7K.
  • Mirabella Financial Services first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 4 quarters.
  • Mirabella Financial Services's Ginkgo Bioworks position peaked at $135K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.